According to ImmunoGen 's latest financial reports the company's total assets are โฌ0.76 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | โฌ0.32 B | -29.93% |
2021-12-31 | โฌ0.46 B | 60.82% |
2020-12-31 | โฌ0.28 B | 37.46% |
2019-12-31 | โฌ0.21 B | -18.66% |
2018-12-31 | โฌ0.25 B | 5.13% |
2017-12-31 | โฌ0.24 B | |
2016-06-30 | โฌ0.25 B | -8.64% |
2015-06-30 | โฌ0.27 B | 126.69% |
2014-06-30 | โฌ0.12 B | -26.2% |
2013-06-30 | โฌ0.16 B | 15.26% |
2012-06-30 | โฌ0.14 B | -5.24% |
2011-06-30 | โฌ0.15 B | 33.98% |
2010-06-30 | โฌ0.11 B | 56.4% |
2009-06-30 | โฌ71.73 M | 35.57% |
2008-06-30 | โฌ52.91 M | -11.57% |
2007-06-30 | โฌ59.83 M | -18.74% |
2006-06-30 | โฌ73.63 M | -19.16% |
2005-06-30 | โฌ91.08 M | -9.5% |
2004-06-30 | โฌ0.10 B | -2.47% |
2003-06-30 | โฌ0.10 B | -32.7% |
2002-06-30 | โฌ0.15 B | -18.14% |
2001-06-30 | โฌ0.18 B |